| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...861539M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0061539 |
| P932 | PMC publication ID | 3629233 |
| P698 | PubMed publication ID | 23613871 |
| P5875 | ResearchGate publication ID | 236277811 |
| P50 | author | Dennis W. Metzger | Q38323275 |
| Meenakshi Malik | Q42134300 | ||
| P2093 | author name string | Sukalyani Banik | |
| Chandra Shekhar Bakshi | |||
| Seham M Rabadi | |||
| Manish Mahawar | |||
| Sally V Catlett | |||
| P2860 | cites work | Characterization of a multigene-encoded sodium/hydrogen antiporter (sha) from Pseudomonas aeruginosa: its involvement in pathogenesis | Q28492735 |
| Possession, use, and transfer of select agents and toxins; biennial review. Final rule | Q30224005 | ||
| Identification of an essential Francisella tularensis subsp. tularensis virulence factor | Q30439303 | ||
| Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. | Q30441155 | ||
| A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge | Q33346284 | ||
| Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy | Q33725674 | ||
| Tularemia as a biological weapon: medical and public health management | Q33949367 | ||
| Francisella tularensis antioxidants harness reactive oxygen species to restrict macrophage signaling and cytokine production | Q34107159 | ||
| Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS. | Q34139968 | ||
| IL-17 in protective immunity to intracellular pathogens | Q34193357 | ||
| A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine | Q34194818 | ||
| Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination | Q34291236 | ||
| Generation and characterization of an attenuated mutant in a response regulator gene of Francisella tularensis live vaccine strain (LVS). | Q34307145 | ||
| Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis | Q34423341 | ||
| Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations | Q34613846 | ||
| Th17 cytokines in recall responses against Francisella tularensis in humans. | Q51045525 | ||
| [Tularemia, a potential bioterrorism weapon] | Q73882925 | ||
| Studies on tularemia. V. Immunization of man | Q75603973 | ||
| Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of th | Q77148368 | ||
| Studies with tularemia vaccines in volunteers. IV. Brucella aggiutinins in vaccinated and nonvaccinated volunteers challenged with Pasteurella tularensis | Q79015693 | ||
| Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis | Q82545647 | ||
| BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge i | Q83831171 | ||
| Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain | Q34975711 | ||
| Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis | Q35009321 | ||
| Superoxide dismutase B gene (sodB)-deficient mutants of Francisella tularensis demonstrate hypersensitivity to oxidative stress and attenuated virulence | Q35075325 | ||
| Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis | Q35224151 | ||
| In vivo negative selection screen identifies genes required for Francisella virulence | Q35699734 | ||
| Vaccines against Francisella tularensis--past, present and future | Q35791781 | ||
| Tularemia: the disease and the weapon | Q35810776 | ||
| Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis | Q35910851 | ||
| Genome-wide identification of Francisella tularensis virulence determinants | Q35913441 | ||
| Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response | Q36127190 | ||
| Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. | Q36191199 | ||
| Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia. | Q36421591 | ||
| Francisella tularensis vaccines | Q36742723 | ||
| Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis. | Q36804275 | ||
| Toxicity of Pasteurella tularensis killed by ionizing radiation | Q36850093 | ||
| An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain | Q37120769 | ||
| Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge | Q37132733 | ||
| T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria | Q37191318 | ||
| Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis | Q37209029 | ||
| Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans | Q37305453 | ||
| Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS. | Q40085788 | ||
| Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis | Q40117823 | ||
| Aerogenic immunization of man with live Tularemia vaccine | Q40720507 | ||
| Identification of Francisella tularensis live vaccine strain CuZn superoxide dismutase as critical for resistance to extracellularly generated reactive oxygen species | Q42134257 | ||
| Recent studies on live tularemia vaccine | Q46496352 | ||
| Virulence of Bacterium tularense. I. A study of the virulence of Bacterium tularense in mice, guinea pigs, and rabbits | Q46720788 | ||
| Responsiveness to acidity via metal ion regulators mediates virulence in the gastric pathogen Helicobacter pylori. | Q47261526 | ||
| Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production | Q50139093 | ||
| Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia | Q50142489 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | attenuated vaccine | Q1810913 |
| P304 | page(s) | e61539 | |
| P577 | publication date | 2013-04-17 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Identification of a live attenuated vaccine candidate for tularemia prophylaxis | |
| P478 | volume | 8 |
| Q55259221 | An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia. |
| Q37438123 | An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy |
| Q60928298 | An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia |
| Q36650280 | Antioxidant Defenses of Francisella tularensis Modulate Macrophage Function and Production of Proinflammatory Cytokines |
| Q35670540 | Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System |
| Q90454734 | Differential In Vitro Cultivation of Francisella tularensis Influences Live Vaccine Protective Efficacy by Altering the Immune Response |
| Q47368891 | Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model |
| Q33899765 | FTT0831c/FTL_0325 contributes to Francisella tularensis cell division, maintenance of cell shape, and structural integrity. |
| Q26771366 | From the Outside-In: The Francisella tularensis Envelope and Virulence |
| Q34490362 | Identification of disulfide bond isomerase substrates reveals bacterial virulence factors. |
| Q55070411 | Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis. |
| Q30411506 | Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain |
| Q35513176 | Preclinical testing of a vaccine candidate against tularemia |
| Q37099716 | Repression of inflammasome by Francisella tularensis during early stages of infection |
| Q50329805 | Vaccine-Mediated Mechanisms Controlling Replication of Francisella tularensis in Human Peripheral Blood Mononuclear Cells Using a Co-culture System |
Search more.